Compare Aurora Cannabis Inc (ACB) vs iShares iBoxx $ High Yield Corporate Bond ETF (HYG) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

HYG trades at $79.87, up 0.2% today, with a neutral technical signal. The ETF shows consistent dividend distributions, including $0.42 in May 2026. Bond ETF inflows are surging 60% year-over-year as investors seek yield amid market volatility and Fed uncertainty, according to CNBC on June 25, 2026. Technical indicators show mixed signals with bearish moving averages but neutral oscillators.

Outlook remains cautious due to interest rate sensitivity and inflation concerns. Risks include potential Fed rate hikes and narrowing market breadth. The high-yield sector faces pressure from bearish bets, but demand for yield provides support. Investors should weigh income stability against macroeconomic headwinds.